Methionine and guanidinoacetic acid supplementation throughout the periconceptual period of gestation altered metabolite concentrations and fetal development in beef heifers

Recent research reported changes in fetal growth due to increased methyl donor availability through periconceptual supplementation of the dam. We hypothesized that maternal supplementation of rumen-protected methionine or unprotected guanidinoacetic acid during the periconceptual period will result in a methyl donor surplus or deficiency in dams, respectively, and ultimately influence fetal development on d 63 of gestation. The objectives of this study were to evaluate the effects of methyl donor surplus or deficiency during the periconceptual period of gestation on metabolite concentrations in the dam, and on early fetal development. Eighty beef heifers (n = 20/treatment, age = 384 ± 10 d, initial BW = 346 ± 8 kg) were stratified by age and weight to one of four treatment groups to receive 100 g total of supplement: ground corn carrier (100 g/d) as control (CON), rumen-protected methionine (10 g/d) in ground corn (90 g/d; MET), unprotected guanidinoacetic acid (40 g/d) in ground corn (60 g/d; GAA), and MET+GAA (10 g/d MET + 40 g/d GAA) in ground corn (50 g/d). Supplementation began 63 d before breeding (d -63), through breeding (d 0), and lasted until d 63 of gestation (d + 63). Serum samples were collected from heifers before feeding on d -63, d 0, and d + 63. Heifers were bred using male sex-sorted semen from a single sire, and 35 heifers were confirmed pregnant (CON, n = 10; MET, n = 8; GAA, n = 7; MET+GAA, n = 10) and harvested on d + 63 of gestation to collect maternal and fetal samples. Data were analyzed as a 2 × 2 factorial arrangement with 2 levels of methionine and 2 levels of guanidinoacetic acid. Methionine concentrations in maternal serum were greater (P = 0.05) in MET and MET+GAA compared with CON and GAA supplemented heifers at breeding on d 0 and d + 63. No differences (P ≥ 0.15) in the concentration of guanidinoacetic acid or creatine were observed between treatment groups; however, both were decreased at breeding (P < 0.01) compared with d -63 and d + 63. Averaged across timepoints, S-adenosyl methionine (SAM) (P = 0.05) and homocysteine (P = 0.01) concentrations in maternal serum were decreased in MET and MET+GAA compared with CON and GAA. Fetuses from MET supplemented dams had greater (P = 0.01) brain and Longissimus dorsi weights compared with those not receiving MET. Supplementation of MET increased maternal serum methionine concentrations and increased early fetal tissue development, suggesting altered methionine utilization in utero.